Search for: "Novartis Vaccines and Diagnostics, Inc." Results 1 - 20 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2010, 7:59 am by fraudfighters
Department of Justice announced that it had reached a settlement agreement with the drug company Novartis Vaccines & Diagnostics, Inc. [read post]
15 Jan 2014, 9:59 pm by Patent Docs
Patent and Trademark Office for fifteen patents were untimely asserted by Novartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation ("Novartis"). [read post]
12 Jul 2010, 9:59 pm by Patent Docs
By Donald Zuhn -- Last week, Novartis AG and Novartis Vaccines and Diagnostics, Inc. filed a complaint against U.S. [read post]
17 May 2010, 7:10 pm by mcarzima@imediainc.com
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals will pay $72.5 million to settle civil False Claims Act allegations that the company caused false claims to be submitted to federal health care programs through its marketing of the drug TOBI. [read post]
25 Aug 2011, 9:31 am by Rantanen
Novartis Vaccines and Diagnostics, Inc. [read post]
22 Feb 2015, 9:59 pm by Patent Docs
Novartis Vaccines and Diagnostics, Inc. et al. v. [read post]
4 May 2010, 10:29 pm by Ben Vernia
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
2 Dec 2007, 8:36 pm
Novartis Vaccines and Diagnostics, Inc. v. [read post]
27 Oct 2009, 8:28 am
Novartis Vaccines and Diagnostics, Inc., C.A. [read post]
25 Feb 2010, 6:30 am by Pilar G. Kraman
Novartis Vaccines and Diagnostics, Inc., C.A. [read post]
23 May 2015, 10:24 pm by Mark Summerfield
Two recent decisions issued by the Australian Patent Office address the requirements for extending the term of a patent encompassing a pharmaceutical substance ‘when produced by a process that involves the use of recombinant DNA technology’: ImmunoGen, Inc. [2014] APO 88 and Novartis Vaccines and Diagnostics S.r.l. [2015] APO 2.What is interesting about both these cases is that, while recombinant DNA techniques are employed in manufacturing the… [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
15 Sep 2009, 2:30 pm
" The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. [read post]
16 Jan 2014, 7:31 pm
  Procedural HistoryNovartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. [read post]
23 Aug 2011, 2:46 pm by Lawrence B. Ebert
-Appellant’s Reply Br. at 10; see also Compl. at 1, Novartis Vaccines & Diagnostics, Inc. v. [read post]